Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults

计划入组 60 人 · 首次发布于 2025 年 7 月 31 日

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

计划入组 105 人 · 首次发布于 2025 年 4 月 29 日

Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002)

计划入组 13 人 · 首次发布于 2024 年 2 月 5 日

STX-1400

STX

BP-1200

1200 Pharma LLC

United States

Pharma 2100 ApS

Denmark

GTX INC

United States

Scribe Therapeutics Demonstrates Breakthrough CRISPR Therapy for Cardiovascular Disease with >90% Lp(a) Reduction

STX-478 Shows Promise as Mutant-Selective PI3Kα Inhibitor in Solid Tumors

Eli Lilly Acquires Scorpion's Cancer Drug STX-478 in $2.5 Billion Deal